成大生物(688739)披露拟参与设立5.02亿元生物医药产业投资基金,2月5日股价上涨0.39%

中金财经
Feb 06

  h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2026年2月5日收盘,成大生物(688739)报收于25.89元,较前一交易日上涨0.39%,最新总市值为107.82亿元。该股当日开盘25.8元,最高26.07元,最低25.71元,成交额达5943.37万元,换手率为0.55%。近日,辽宁成大生物股份有限公司披露《2026年第一次临时股东会会议资料》。公告显示,公司拟与控股股东辽宁成大及其全资子公司共同发起设立成大生物医药产业投资基金,基金设立规模为50,200万元,公司作为有限合伙人认缴出资4亿元。同时,公司全资子公司深圳成大生物与辽宁成大全资子公司成大医疗按比例共同对北京基因启明生物科技有限公司增资,后续由产业基金平价受让相关股权。本次事项构成关联交易,需提交股东大会审议。最新公告列表《辽宁成大生物股份有限公司2026年第一次临时股东会会议资料》为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10